42nd Annual J.P. Morgan Healthcare Conference

The 42nd Annual J.P. Morgan Healthcare Conference is set to take place from January 8 to 11, 2024, in San Francisco, California. By invitation only, it stands as the largest global healthcare investment symposium.

Participants: 

Over 8,000 attendees, including investors, industry professionals, government officials, and representatives from 550 global healthcare companies.

Focus Areas:

  - Discussion on cutting-edge market trends and medical innovations.

  - Unveiling breakthrough drugs and transformative healthcare solutions.

Past Highlights:

  - 41st edition showcased groundbreaking drugs for Alzheimer’s and diabetes.

 - Notable FDA approval for Biogen's Alzheimer’s drug, Lecanemab, offering hope in slowing cognitive decline.

Deals and Advancements:

  - Over $3.5 billion worth of transactions announced pre-event.

 - Continued momentum from J.P. Morgan's Global Head of Healthcare Investment Banking, Mike Gaito.

 - Healthcare and technology intersection driving M&A, especially in AI and machine learning.

Economic Insights:

  - Sessions exploring broader economic and geopolitical landscapes.

  - Jamie Dimon, J.P. Morgan's CEO, optimistic about U.S. economy and financial system resilience.

Anticipation:

  - Industry eagerly awaits unveiling of critical healthcare trends, breakthroughs, and potential game-changing deals.

Stay tuned for updates as the conference unfolds! For more information, visit https://www.jpmorgan.com/about-us/events-conferences/health-care-conference